| Year |
Title |
Altmetric |
| 2020
|
Downregulated AKT-mTOR signaling pathway proteins in dorsolateral prefrontal cortex in Schizophrenia.
Neuropsychopharmacology.
45:1059-1067.
2020
|
|
| 2020
|
AMPA receptor subunit localization in schizophrenia anterior cingulate cortex.
Schizophrenia Research.
2020
|
|
| 2019
|
Abnormal ER quality control of neural GPI-anchored proteins via dysfunction in ER export processing in the frontal cortex of elderly subjects with schizophrenia.
Translational Psychiatry.
9.
2019
|
|
| 2019
|
Dysregulation of the unfolded protein response (UPR) in the dorsolateral prefrontal cortex in elderly patients with schizophrenia.
Molecular Psychiatry.
2019
|
|
| 2019
|
Fractionation of subcellular compartments from human brain tissue.
Methods in Molecular Biology.
1941:201-223.
2019
|
|
| 2019
|
Intracellular compartment-specific proteasome dysfunction in postmortem cortex in schizophrenia subjects.
Molecular Psychiatry.
2019
|
|
| 2019
|
Kinase network dysregulation in a human induced pluripotent stem cell model of DISC1 schizophrenia.
Molecular Omics.
15:173-188.
2019
|
|
| 2018
|
Abnormal expression of ER quality control and ER associated degradation proteins in the dorsolateral prefrontal cortex in schizophrenia.
Schizophrenia Research.
197:484-491.
2018
|
|
| 2017
|
Abnormalities of signal transduction networks in chronic schizophrenia.
npj Schizophrenia.
3.
2017
|
|
| 2017
|
Actin polymerization is reduced in the anterior cingulate cortex of elderly patients with schizophrenia.
Translational Psychiatry.
7.
2017
|
|
| 2017
|
Pre-clinical Medical Students as the Primary Longitudinal Provider of Psychiatric Care in the Outpatient Setting: A Novel Training Model.
Academic Psychiatry.
41:538-541.
2017
|
|
| 2017
|
Altered fucosyltransferase expression in the superior temporal gyrus of elderly patients with schizophrenia.
Schizophrenia Research.
182:66-73.
2017
|
|
| 2017
|
Abnormalities of signal transduction networks in chronic schizophrenia..
npj Schizophrenia.
3:30.
2017
|
|
| 2016
|
Decreased protein S-palmitoylation in dorsolateral prefrontal cortex in schizophrenia.
Schizophrenia Research.
177:78-87.
2016
|
|
| 2016
|
Cell-specific abnormalities of glutamate transporters in schizophrenia: Sick astrocytes and compensating relay neurons?.
Molecular Psychiatry.
21:823-830.
2016
|
|
| 2016
|
Shaping plasticity: Alterations in glutamate transporter localization as a pathophysiological mechanism in severe mental illness..
Molecular Psychiatry.
21:723.
2016
|
|
| 2016
|
Changes in cortical N-methyl-d-aspartate receptors and post-synaptic density protein 95 in schizophrenia, mood disorders and suicide.
Australian and New Zealand Journal of Psychiatry.
50:275-283.
2016
|
|
| 2016
|
Protein Expression of Proteasome Subunits in Elderly Patients with Schizophrenia.
Neuropsychopharmacology.
41:896-905.
2016
|
|
| 2016
|
Decreased expression of cortactin in the schizophrenia brain.
NeuroReport.
27:145-150.
2016
|
|
| 2016
|
Cortical PGC-1?-dependent transcripts are reduced in postmortem tissue from patients with schizophrenia.
Schizophrenia Bulletin.
42:1009-1017.
2016
|
|
| 2015
|
Abnormal subcellular localization of GABA A receptor subunits in schizophrenia brain.
Translational Psychiatry.
5.
2015
|
|
| 2015
|
Glutamate transporter splice variant expression in an enriched pyramidal cell population in schizophrenia.
Translational Psychiatry.
5.
2015
|
|
| 2015
|
Abnormal N-acetylglucosaminyltransferase expression in prefrontal cortex in schizophrenia.
Schizophrenia Research.
166:219-224.
2015
|
|
| 2015
|
Corrigenda - Postmortem Brain: An Underutilized Substrate for Studying Severe Mental Illness (Neuropsychopharmacology Reviews (2014) 39, (65-87) DOI: 10.1038/npp.2013.239).
Neuropsychopharmacology.
40:1307.
2015
|
|
| 2014
|
Altered serine/threonine kinase activity in schizophrenia.
Brain Research.
1568:42-54.
2014
|
|
| 2014
|
Evolutionarily conserved pattern of AMPA receptor subunit glycosylation in mammalian frontal cortex.
PLoS ONE.
9.
2014
|
|
| 2014
|
N-glycosylation of GABAA receptor subunits is altered in schizophrenia.
Neuropsychopharmacology.
39:528-537.
2014
|
|
| 2014
|
Abnormal partitioning of hexokinase 1 suggests disruption of a glutamate transport protein complex in schizophrenia.
Schizophrenia Research.
154:1-13.
2014
|
|
| 2014
|
Alterations of the myristoylated, alanine-rich C kinase substrate (MARCKS) in prefrontal cortex in schizophrenia.
Schizophrenia Research.
154:36-41.
2014
|
|
| 2014
|
Increased G protein-coupled receptor kinase (GRK) expression in the anterior cingulate cortex in schizophrenia.
Schizophrenia Research.
159:130-135.
2014
|
|
| 2014
|
Postmortem brain: An underutilized substrate for studying severe mental illness.
Neuropsychopharmacology.
39:65-87.
2014
|
|
| 2013
|
Dysfunction of the ubiquitin proteasome and ubiquitin-like systems in schizophrenia.
Neuropsychopharmacology.
38:1910-1920.
2013
|
|
| 2013
|
N-linked glycosylation of cortical N-methyl-D-aspartate and kainate receptor subunits in schizophrenia.
NeuroReport.
24:688-691.
2013
|
|
| 2013
|
Erratum: Gene expression of glutamate metabolizing enzymes in the hippocampal formation in human temporal lobe epilepsy (Epilepsia (2013) 54 228-238).
Epilepsia.
54:1140.
2013
|
|
| 2013
|
Transmembrane AMPA receptor regulatory protein (TARP) dysregulation in anterior cingulate cortex in schizophrenia.
Schizophrenia Research.
147:32-38.
2013
|
|
| 2013
|
Abnormal N-linked glycosylation of cortical AMPA receptor subunits in schizophrenia.
Schizophrenia Research.
146:177-183.
2013
|
|
| 2013
|
Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia.
Schizophrenia Research.
144:1-8.
2013
|
|
| 2013
|
Gene expression of glutamate metabolizing enzymes in the hippocampal formation in human temporal lobe epilepsy.
Epilepsia.
54:228-238.
2013
|
|
| 2012
|
Upregulation of cornichon transcripts in the dorsolateral prefrontal cortex in schizophrenia.
NeuroReport.
23:1031-1034.
2012
|
|
| 2012
|
Ampa receptor subunit expression in the endoplasmic reticulum in frontal cortex of elderly patients with schizophrenia.
PLoS ONE.
7.
2012
|
|
| 2012
|
Recent advances in targeting the ionotropic glutamate receptors in treating schizophrenia.
Current Pharmaceutical Biotechnology.
13:1535-1542.
2012
|
|
| 2012
|
Abnormalities of the Duo/Ras-related C3 botulinum toxin substrate 1/p21-activated kinase 1 pathway drive myosin light chain phosphorylation in frontal cortex in schizophrenia.
Biological Psychiatry.
71:906-914.
2012
|
|
| 2012
|
Expression of equilibrative nucleoside transporter type 1 protein in elderly patients with schizophrenia.
NeuroReport.
23:224-227.
2012
|
|
| 2012
|
Abnormal activity of the MAPK- and cAMP-associated signaling pathways in frontal cortical areas in postmortem brain in schizophrenia.
Neuropsychopharmacology.
37:896-905.
2012
|
|
| 2012
|
Regional differences in expression of β-tubulin isoforms in schizophrenia.
Schizophrenia Research.
135:181-186.
2012
|
|
| 2012
|
Glutamate receptor abnormalities in schizophrenia: Implications for innovative treatments
2012
|
|
| 2011
|
Glutamatergic gene expression is specifically reduced in thalamocortical projecting relay neurons in schizophrenia.
Biological Psychiatry.
70:646-654.
2011
|
|
| 2011
|
Endosomal trafficking of AMPA receptors in frontal cortex of elderly patients with schizophrenia.
Schizophrenia Research.
130:260-265.
2011
|
|
| 2011
|
Novel approaches to the study of postmortem brain in psychiatric illness: Old limitations and new challenges.
Biological Psychiatry.
69:127-133.
2011
|
|
| 2011
|
Innovative approach to research training: Research colloquium for junior investigators.
Academic Psychiatry.
35:11-14.
2011
|
|
| 2010
|
Increased cortical expression of an RNA editing enzyme occurs in major depressive suicide victims.
NeuroReport.
21:993-997.
2010
|
|
| 2010
|
Evidence for abnormal forward trafficking of AMPA receptors in frontal cortex of elderly patients with schizophrenia.
Neuropsychopharmacology.
35:2110-2119.
2010
|
|
| 2010
|
Expression of the NR2B-NMDA receptor subunit and its Tbr-1/CINAP regulatory proteins in postmortem brain suggest altered receptor processing in schizophrenia
2010
|
|
| 2010
|
Expression of the NR2B-NMDA receptor trafficking complex in prefrontal cortex from a group of elderly patients with schizophrenia.
Schizophrenia Research.
119:198-209.
2010
|
|
| 2010
|
Parvalbumin deficiency and GABAergic dysfunction in mice lacking PGC-1α
2010
|
|
| 2010
|
Late emerging effects of prenatal and early postnatal nicotine exposure on the cholinergic system and anxiety-like behavior.
Neurotoxicology and Teratology.
32:336-345.
2010
|
|
| 2010
|
Abnormal glycosylation of EAAT1 and EAAT2 in prefrontal cortex of elderly patients with schizophrenia.
Schizophrenia Research.
117:92-98.
2010
|
|
| 2009
|
Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia
2009
|
|
| 2009
|
Decreased expression of NMDA receptor-associated proteins in frontal cortex of elderly patients with schizophrenia.
NeuroReport.
20:1019-1022.
2009
|
|
| 2009
|
Expression of four housekeeping proteins in elderly patients with schizophrenia.
Journal of Neural Transmission.
116:487-491.
2009
|
|
| 2009
|
Identification of novel targets for PGC-1α and histone deacetylase inhibitors in neuroblastoma cells.
Biochemical and Biophysical Research Communications.
379:578-582.
2009
|
|
| 2009
|
Expression of transcripts for myelin related genes in postmortem brain from cocaine abusers.
Neurochemical Research.
34:46-54.
2009
|
|
| 2008
|
Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia.
Schizophrenia Research.
104:108-120.
2008
|
|
| 2008
|
Role of glutamate in schizophrenia: Integrating excitatory avenues of research
2008
|
|
| 2008
|
Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia.
Schizophrenia Research.
103:71-82.
2008
|
|
| 2008
|
Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder.
Neuropsychopharmacology.
33:2175-2186.
2008
|
|
| 2008
|
Contribution of cystine-glutamate antiporters to the psychotomimetic effects of phencyclidine.
Neuropsychopharmacology.
33:1760-1772.
2008
|
|
| 2008
|
Altered Vesicular Glutamate Transporter Expression in the Anterior Cingulate Cortex in Schizophrenia.
Biological Psychiatry.
63:766-775.
2008
|
|
| 2007
|
Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders.
Neuropsychopharmacology.
32:1888-1902.
2007
|
|
| 2007
|
Expression of transcripts for myelination-related genes in the anterior cingulate cortex in schizophrenia.
Schizophrenia Research.
90:15-27.
2007
|
|
| 2007
|
NMDA receptors and schizophrenia.
Current Opinion in Pharmacology.
7:48-55.
2007
|
|
| 2007
|
Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder.
Brain Research.
1127:108-118.
2007
|
|
| 2006
|
Lamina-specific abnormalities of AMPA receptor trafficking and signaling molecule transcripts in the prefrontal cortex in schizophrenia
2006
|
|
| 2006
|
Dopamine receptor signaling molecules are altered in elderly schizophrenic cortex
2006
|
|
| 2006
|
Plasma copper, iron, ceruloplasmin and ferroxidase activity in schizophrenia.
Schizophrenia Research.
86:167-171.
2006
|
|
| 2006
|
Altered NMDA receptor expression in schizophrenia.
Molecular Psychiatry.
11:705.
2006
|
|
| 2006
|
Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia.
Molecular Psychiatry.
11:737-747.
2006
|
|
| 2006
|
Up-regulation of NMDA receptor subunit and post-synaptic density protein expression in the thalamus of elderly patients with schizophrenia.
Journal of Neurochemistry.
98:1114-1125.
2006
|
|
| 2006
|
Serine racemase protein expression in cortex and hippocampus in schizophrenia.
NeuroReport.
17:1181-1185.
2006
|
|
| 2006
|
Expression of excitatory amino acid transporter interacting protein transcripts in the thalamus in schizophrenia
2006
|
|
| 2006
|
Glutamatergic mechanisms in schizophrenia: Current concepts.
Current Psychosis and Therapeutics Reports.
4:27-34.
2006
|
|
| 2006
|
Reply to Balcar and Nanitsos. Reply: Autoradiography of [ 3H]aspartate and glutamate transport in schizophrenia [2].
Neuropsychopharmacology.
31:687-688.
2006
|
|
| 2005
|
Abnormal striatal expression of transcripts encoding NMDA interacting PSD proteins in schizophrenia, bipolar disorder and major depression.
Schizophrenia Research.
78:87-93.
2005
|
|
| 2005
|
Dopaminergic abnormalities in select thalamic nuclei in schizophrenia: Involvement of the intracellular signal integrating proteins calcyon and spinophilin.
American Journal of Psychiatry.
162:1859-1871.
2005
|
|
| 2005
|
Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia
2005
|
|
| 2005
|
Cortical glutamatergic markers in schizophrenia.
Neuropsychopharmacology.
30:1521-1531.
2005
|
|
| 2005
|
Dopaminergic regulation of orexin neurons.
European Journal of Neuroscience.
21:2993-3001.
2005
|
|
| 2005
|
Increased expression of glutaminase and glutamine synthetase mRNA in the thalamus in schizophrenia.
Schizophrenia Research.
75:27-34.
2005
|
|
| 2005
|
Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains.
Biological Psychiatry.
57:252-260.
2005
|
|
| 2005
|
Distribution of the NMDA receptor NR3A subunit in the adult pig-tail macaque brain.
Journal of Chemical Neuroanatomy.
29:157-172.
2005
|
|
| 2004
|
NR3A NMDA receptor subunit mRNA expression in schizophrenia, depression and bipolar disorder.
Schizophrenia Research.
71:361-370.
2004
|
|
| 2004
|
Thalamic dysfunction in schizophrenia: Neurochemical, neuropathological, and in vivo imaging abnormalities.
Schizophrenia Research.
69:237-253.
2004
|
|
| 2004
|
Abnormalities of the NMDA receptor and associated intracellular molecules in the thalamus in schizophrenia and bipolar disorder.
Neuropsychopharmacology.
29:1353-1362.
2004
|
|
| 2004
|
Molecular abnormalities of the hippocampus in severe psychiatric illness: Postmortem findings from the Stanley Neuropathology Consortium.
Molecular Psychiatry.
9:609-620.
2004
|
|
| 2004
|
Molecular abnormalities of the hippocampus in severe psychiatric illness: Postmortem findings from the Stanley Neuropathology Consortium.
Molecular Psychiatry.
9:544.
2004
|
|
| 2004
|
Neurocognitive measures of prefrontal cortical dysfunction in schizophrenia.
Schizophrenia Research.
68:65-73.
2004
|
|
| 2004
|
Effects of 6-Cyano-7-nitroquinoxaline-2,3-dione on Nicotinic Receptor Subunit Transcript Expression in the Rat Brain
2004
|
|
| 2004
|
Expression of the ionotropic glutamate receptor subunits and NMDA receptor-associated intracellular proteins in the substantia nigra in schizophrenia.
Brain Research.
121:60-69.
2004
|
|
| 2004
|
Gender-Specific Gene Expression in Post-Mortem Human Brain: Localization to Sex Chromosomes.
Neuropsychopharmacology.
29:373-384.
2004
|
|
| 2004
|
Expression of Transcripts Encoding AMPA Receptor Subunits and Associated Postsynaptic Proteins in the Macaque Brain.
Journal of Comparative Neurology.
468:530-554.
2004
|
|
| 2004
|
Calcyon Transcript Expression in Macaque Brain.
Journal of Comparative Neurology.
468:264-276.
2004
|
|
| 2004
|
Neurofilament subunit protein abnormalities in the thalamus in schizophrenia.
Thalamus and Related Systems.
2:265-272.
2004
|
|
| 2003
|
Differential effects of antipsychotics on haloperidol-induced vacuous chewing movements and subcortical gene expression in the rat
2003
|
|
| 2003
|
Altered transcript expression of NMDA receptor-associated postsynaptic proteins in the thalamus of subjects with schizophrenia.
American Journal of Psychiatry.
160:1100-1109.
2003
|
|
| 2003
|
DNA microarray analysis of functionally discrete human brain regions reveals divergent transcriptional profiles.
Neurobiology of Disease.
14:240-250.
2003
|
|
| 2002
|
Ontogeny of ionotropic glutamate receptor subunit expression in the rat hippocampus
2002
|
|
| 2002
|
Striatal Excitatory Amino Acid Transporter Transcript Expression in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder.
Neuropsychopharmacology.
26:368-375.
2002
|
|
| 2002
|
Nucleus-specific expression of NMDA receptor-associated postsynaptic density proteins in primate thalamus.
Thalamus and Related Systems.
1:303-316.
2002
|
|
| 2001
|
Gene expression in schizophrenia [9].
American Journal of Psychiatry.
158:1740-1741.
2001
|
|
| 2001
|
Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia.
American Journal of Psychiatry.
158:1393-1399.
2001
|
|
| 2001
|
Vesicular glutamate transporter transcript expression in the thalamus in schizophrenia.
NeuroReport.
12:2885-2887.
2001
|
|
| 2001
|
Striatal ionotropic glutamate receptor expression in schizophrenia, bipolar disorder, and major depressive disorder.
Brain Research Bulletin.
55:631-640.
2001
|
|
| 2001
|
Ontogeny of ionotropic glutamate receptor expression in human fetal brain
2001
|
|
| 2001
|
Abnormal kainate receptor expression in prefrontal cortex in schizophrenia.
Neuropsychopharmacology.
24:545-552.
2001
|
|
| 2000
|
Ionotropic glutamate receptor modulation preferentially affects NMDA receptor expression in rat hippocampus
2000
|
|
| 2000
|
Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia.
American Journal of Psychiatry.
157:1811-1823.
2000
|
|
| 2000
|
New initiative: Neuropsychopharmacology online rapid publication.
Neuropsychopharmacology.
23:221-222.
2000
|
|
| 2000
|
Nucleus-specific expression of ionotropic glutamate receptor subunit mRNAs and binding sites in primate thalamus.
Brain Research.
79:1-17.
2000
|
|
| 2000
|
Metabotropic glutamate receptor mRNA expression in the schizophrenic thalamus.
Biological Psychiatry.
47:22-28.
2000
|
|
| 1999
|
Ionotropic glutamate receptor modulation of 5-HT6 and 5-HT7 mRNA expression in rat brain.
Neuropsychopharmacology.
21:341-351.
1999
|
|
| 1999
|
Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia.
Neuropsychopharmacology.
21:195-202.
1999
|
|
| 1999
|
Effects of clozapine and haloperidol on 5-HT6 receptor mRNA levels in rat brain.
Schizophrenia Research.
38:7-12.
1999
|
|
| 1999
|
On the distribution patterns of D1, D2, tyrosine hydroxylase and dopamine transporter immunoreactivities in the ventral striatum of the rat.
Neuroscience.
89:473-489.
1999
|
|
| 1999
|
Acute feasibility and safety of a smoking reduction strategy for smokers with schizophrenia.
Nicotine and Tobacco Research.
1:53-57.
1999
|
|
| 1998
|
AMPA receptor binding and subunit mRNA expression in prefrontal cortex and striatum of elderly schizophrenics.
Neuropsychopharmacology.
19:278-286.
1998
|
|
| 1998
|
Differential prevalence of cigarette smoking in patients with schizophrenic vs mood disorders.
Schizophrenia Research.
33:113-118.
1998
|
|
| 1998
|
The role of life events in onset and recurrent episodes of schizophrenia and schizoaffective disorder.
Journal of Psychiatric Research.
32:283-288.
1998
|
|
| 1998
|
Tardive dyskinesia, clozapine, and treatment response.
Progress in Neuro-Psychopharmacology and Biological Psychiatry.
22:567-573.
1998
|
|
| 1998
|
Nicotine dependence in schizophrenia: Clinical phenomena and laboratory findings.
American Journal of Psychiatry.
155:1490-1501.
1998
|
|
| 1997
|
Clozapine-reserpine combination for refractory psychosis.
Schizophrenia Research.
25:259-260.
1997
|
|
| 1997
|
Antipsychotic regulation of hippocampal dopamine receptor messenger RNA expression.
Biological Psychiatry.
42:155-164.
1997
|
|
| 1997
|
Clozapine and haloperidol differentially affect AMPA and kainate receptor subunit mRNA levels in rat cortex and striatum.
Brain Research.
47:331-338.
1997
|
|
| 1997
|
Linking the family of D2 receptors to neuronal circuits in human brain: Insights into schizophrenia.
Neuropsychopharmacology.
16:375-384.
1997
|
|
| 1997
|
Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex: Focal abnormalities in orbitofrontal cortex in schizophrenia.
Archives of General Psychiatry.
54:1089-1095.
1997
|
|
| 1997
|
Editorial.
Journal of Psychiatric Research.
31:157-158.
1997
|
|
| 1997
|
Serotonin transporter mRNA in schizophrenia (multiple letters) [1].
Molecular Psychiatry.
2:446-447.
1997
|
|
| 1996
|
Lack of dopamine receptor agonists effect on striatal dopamine transporter binding sites.
Brain Research.
742:313-316.
1996
|
|
| 1996
|
Differential regulation of hippocampal AMPA and kainate receptor subunit expression by haloperidol and clozapine.
Molecular Psychiatry.
1:41-53.
1996
|
|
| 1996
|
Smoking, smoking withdrawal and schizophrenia: Case reports and a review of the literature.
Schizophrenia Research.
22:133-141.
1996
|
|
| 1996
|
Differential effects of clozapine and haloperidol on dopamine receptor mRNA expression in rat striatum and cortex.
Brain Research.
41:241-249.
1996
|
|
| 1996
|
Dopamine receptor gene expression in hippocampus is differentially regulated by the NMDA receptor antagonist MK-801
1996
|
|
| 1996
|
Differential regulation, by MK-801, of dopamine receptor gene expression in rat nigrostriatal and mesocorticolimbic systems.
Brain Research.
708:38-44.
1996
|
|
| 1996
|
Dopamine receptor mRNA expression in human striatum and neocortex.
Neuropsychopharmacology.
15:17-29.
1996
|
|
| 1996
|
Frequency of neuropathology in a brain bank from a long-term, domiciliary population.
Journal of Psychiatric Research.
30:45-49.
1996
|
|
| 1995
|
Effects of cocaine on D3 and D4 receptor expression in the human striatum.
Biological Psychiatry.
38:263-266.
1995
|
|
| 1995
|
The Human Dopamine D5 Receptor Gene: Cloning and Characterization of the 5′-Flanking and Promoter Region.
Biochemistry.
34:5960-5970.
1995
|
|
| 1995
|
Neocortical Abnormalities in Schizophrenia.
Archives of General Psychiatry.
52:819-820.
1995
|
|
| 1994
|
Differential expression of autoreceptors in the ascending dopamine systems of the human brain
1994
|
|
| 1994
|
Ventricular enlargement, neuropsychological status, and premorbid function in schizophrenia.
Biological Psychiatry.
35:517-524.
1994
|
|
| 1994
|
Dopamine receptor gene expression in the human medial temporal lobe.
Neuropsychopharmacology.
10:239-248.
1994
|
|
| 1994
|
Human brain receptors, V: Binding and message.
American Journal of Psychiatry.
151:804.
1994
|
|
| 1994
|
Prodynorphin-derived peptide expression in primate cortex and striatum.
Neuropeptides.
27:277-284.
1994
|
|
| 1994
|
Update on dopamine receptors.
Annals of Clinical Psychiatry.
6:79-90.
1994
|
|
| 1993
|
Effects of cocaine on dopamine receptor gene expression: A study in the postmortem human brain.
Biological Psychiatry.
34:348-355.
1993
|
|
| 1993
|
Characterization of pro-opiomelanocortin processing in heterologous neuronal cells that express PC2 mRNA.
Neuropeptides.
24:253-262.
1993
|
|
| 1993
|
Expression of prodynorphin-derived peptides and mRNA in guinea-pig cortex.
Neuropeptides.
25:131-138.
1993
|
|
| 1992
|
Distribution of D5 dopamine receptor mRNA in rat brain.
Neuroscience Letters.
145:209-212.
1992
|
|
| 1992
|
Site-directed mutagenesis of the human dopamine D2 receptor
1992
|
|
| 1992
|
A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques.
Neuroscience.
46:959-971.
1992
|
|
| 1991
|
Comparison of the distributions of D1 and D2 dopamine receptor mRNAs in the rat brain.
Neuropsychopharmacology.
5:231-242.
1991
|
|
| 1991
|
Expression of the dopamine D2 receptor gene in brain.
Biological Psychiatry.
30:985-1007.
1991
|
|
| 1991
|
Dexamethasone suppression test in schizophrenia: Relationship to symptomatology, ventricular enlargement, and outcome.
Biological Psychiatry.
29:953-964.
1991
|
|
| 1991
|
Basal ganglia mineralization in schizophrenia.
Biological Psychiatry.
29:296-297.
1991
|
|
| 1991
|
A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques.
Neuroscience.
45:359-371.
1991
|
|
| 1991
|
Distribution of D2 dopamine receptor mRNA in the primate brain.
Progress in Neuro-Psychopharmacology and Biological Psychiatry.
15:885-893.
1991
|
|
| 1991
|
Opiate Receptors: Opioid Agonist‐Antagonist Effects
1991
|
|
| 1990
|
Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: An in situ hybridization-receptor autoradiographic analysis
1990
|
|
| 1990
|
Multiplicity of depressive episodes: Phenomenological and neuroendocrine correlates.
Biological Psychiatry.
27:1156-1164.
1990
|
|
| 1990
|
Differential effects of haloperidol on the rat pituitary: Decreased biosynthesis, processing and release of anterior lobe pro-opiomelanocortin
1990
|
|
| 1990
|
Psychiatric side effects of tricyclic antidepressants.
Hospital & community psychiatry.
41:84-86.
1990
|
|
| 1990
|
Severity of depression and hypothalamic‐pituitary‐adrenal axis dysregulation: identification of contributing factors.
Acta Psychiatrica Scandinavica.
81:364-371.
1990
|
|
| 1990
|
The effects of nigrostriatal 6-hydroxydopamine lesions on dopamine D2 receptor mRNA and opioid systems..
Progress in clinical and biological research.
328:227-230.
1990
|
|
| 1989
|
γ-melanotropin and β-endorphin after dexamethasone.
Biological Psychiatry.
25:975-976.
1989
|
|
| 1989
|
Positive and negative symptoms in schizophrenia and the dexamethasone suppression test.
Biological Psychiatry.
25:788-792.
1989
|
|
| 1989
|
Distribution of D2 dopamine receptor mRNA in rat brain
1989
|
|
| 1988
|
Behavioral and cognitive toxicity related to elevated plasma tricyclic antidepressant levels.
Journal of Clinical Psychopharmacology.
8:28-32.
1988
|
|
| 1988
|
Dexamethasone suppression test status and severity of depression.
Biological Psychiatry.
24:693-696.
1988
|
|
| 1988
|
Doxepin-induced cardiac dysrhythmia.
Journal of Clinical Psychopharmacology.
8:144-145.
1988
|
|
| 1988
|
Effects of psychotropic medications on hypothalamic-pituitary-adrenal regulation.
Endocrinology and Metabolism Clinics of North America.
17:225-234.
1988
|
|
| 1988
|
Effects of psychotropic medications on hypothalamic-pituitary-adrenal regulation.
Endocrinology and Metabolism Clinics of North America.
17:225-234.
1988
|
|
| 1988
|
Plasma postdexamethasone cortisol levels in schizoaffective disorder.
Psychiatry Research.
26:35-42.
1988
|
|
| 1988
|
Regional processing of the N- and C-terminal domains of proopiomelanocortin in monkey pituitary and brain.
Neuropeptides.
11:111-118.
1988
|
|
| 1987
|
Gamma-melanotropin response to ovine corticotropin releasing factor in normal humans.
Neuropeptides.
9:269-282.
1987
|
|
| 1987
|
Multiple depressive episodes and plasma postdexamethasone cortisol levels.
Biological Psychiatry.
22:583-592.
1987
|
|
| 1987
|
Postdexamethasone plasma cortisol and β-endorphin levels in depression: Relationship to severity of illness.
Biological Psychiatry.
22:1137-1150.
1987
|
|
| 1986
|
Gamma-3-MSH and beta-endorphin in monkey pituitary..
NIDA research monograph.
75:307-310.
1986
|
|
| 1986
|
Profound behavioral toxicity due to tricyclic antidepressants.
Journal of Nervous and Mental Disease.
174:628-630.
1986
|
|
| 1985
|
Differential proliferative responses of cultured Schwann cells to axolemma and myelin-enriched fractions. II. Morphological studies.
Journal of Neurocytology.
14:619-635.
1985
|
|
| 1984
|
Differential proliferative responses of cultured Schwann cells to axolemma- and myelin-enriched fractions. I. Biochemical studies
1984
|
|
| 1984
|
Cyclic AMP and calcium as potential mediators of stimulation of cultured Schwann cell proliferation by axolemma-enriched and myelin-enriched membrane fractions.
Biochemical and Biophysical Research Communications.
122:373-380.
1984
|
|
